Riyadh, Saudi Arabia and Paris, April 08, 2026–(business telegram)–Pascal, a global leader in neutral-atom quantum computing, today announced a strategic collaboration with True Nexus, a computational intelligence company focused on making protein functionality programmable for real-world food applications. Pascal recently announced plans to go public through a combination with Bleichroeder Acquisition Corp. II (NASDAQ: BBCQ).
This collaboration will apply Pascal’s quantum computing technology to one of the most persistent challenges in the alternative protein and food industries: accurate modeling and prediction of protein functionality; Gelatin, texture and aggregate behavior, especially in complex food systems.
“For decades, the industry has been hampered by a lack of true computational understanding of protein behavior,” said Dominic Grabinski, CEO of True Nexus. “The partnership with Pascal allows us to model protein functionality at a level of fidelity that was not possible before. This is a breakthrough that could move the entire field from trial-and-error to real design.”
As part of the collaboration, Pascal and True Nexus are working to create the first fully vectorized, dynamic 3D model of protein gelation, one of the most important functional properties in food systems.
The model integrates multiple layers of data, including:
Protein Extraction Parameters
molecular structure
Processing and environmental conditions
End-use application requirements
Pascal’s neutral-atom quantum processors will enable models to capture interactions and variables at a level of accuracy that cannot be achieved with classical computing alone.
“Quantum computing allows us to tackle complexity that has limited innovation for decades,” said Wasik Bokhari, CEO of Pascal. “Together with True Nexus, we are helping to enable a more scalable, design-driven approach to sustainable protein development.”
The long-term goal of the collaboration is to establish a reference model for protein functionality that food and ingredient companies can use to guide seed development, crop optimization and precision fermentation when existing proteins are lacking.
The inability to consistently match animal-protein functionality has been a major barrier to the adoption of alternative proteins. By making protein behavior predictable and programmable, the collaboration between Pascal and True Nexus addresses a critical gap that has slowed the industry’s progress.
about pascal
Pascal is a leader in the industrialization of neutral-atom quantum computing, transforming Nobel Prize-winning research into real-world solutions for industry, science, and governments. Since its founding in 2019, Pascal has built high-performance quantum systems and cloud-ready software designed to solve complex challenges in optimization, simulation, and artificial intelligence.
Pascal, which is headquartered in France, employs more than 275 people and serves more than 25 customers, including CMA CGM, OVHCloud, Thales, IBM (Pascal is part of the IBM Quantum Network) and Sumitomo. Backed by a total of more than US$300 million in funding to date from international investors, Pascal seeks to accelerate the adoption of scalable, high-performance quantum computing around the world.
About True Nexus
True Nexus is a Saudi-based computational intelligence company focused on making protein functionality programmable. By combining artificial intelligence, advanced data infrastructure and frontier computing approaches, the company enables food and ingredient innovators to better understand, predict and design protein behavior under real-world conditions.
Its work addresses a long-standing lack of functionality that has slowed the adoption of alternative proteins in the food industry, a gap illustrated by the field’s continued difficulty, even after more than 20 years of effort, in replacing something as simple as gelatin in gummy bears.
forward-looking statements
Certain statements herein may be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements typically include words such as “believe,” “could,” “could,” “will,” “estimate,” “will continue,” “anticipate,” “intend,” “expect,” “should,” “will,” “could.” “Plan,” “predict,” “project,” “forecast,” “believe,” “potential,” “think,” “seek,” “target,” “possible,” “future,” “outlook” or similar terminology or expressions that predict or imply future events or trends. These forward-looking statements include, but are not limited to, statements regarding future events, the proposed business combination between Bleichroeder Acquisition Corp. II (“Bleichroeder”) and Pascal Holding SAS (“Pascal”) and the estimated or anticipated future results and benefits of Pascal’s strategic collaboration with True Nexus.
These statements are based on current expectations and are not predictions of actual performance. These are provided for illustrative purposes only and should not be relied upon as a guarantee, prediction, or definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and are beyond the control of Bleichroeder and Pascal. These statements are subject to known and unknown risks, uncertainties and assumptions regarding Pascal’s business and the business combination, and actual results may differ materially. These risks and uncertainties include, but are not limited to: general economic, political, social and business conditions; uncertainty or changes regarding laws and regulations; inability of the parties to complete a business combination, failure to realize the anticipated benefits of the business combination; The risk that the business combination disrupts Pascal’s current plans and operations; the risk that Pascal, pursuing an emerging technology, will face significant technical challenges and the possibility that it may not achieve commercialization or market acceptance; Pascal’s dependence on strategic partners and other third parties; Pascal’s ability to maintain, preserve and defend its intellectual property rights; and other risks that will be described from time to time in filings with the U.S. Securities and Exchange Commission (“SEC”). The above list of risk factors is not exhaustive. There may also be additional risks that Pascal and Bleichroeder are not currently aware of or currently believe to be immaterial, which could cause actual results to differ materially from those implied by the forward-looking statements. In addition, forward-looking statements provide Pascal’s and/or Bleichroeder’s expectations, plans and forecasts of future events and views as of the date of this communication. While Pascal and/or Bleichroeder may elect to update these forward-looking statements in the future, Pascal and Bleichroeder specifically disclaim any obligation to do so.
Additional information and where to find it
The business combination will be presented to Bleichroeder’s shareholders for their consideration. In connection with the Business Combination, Bleichroeder intends to file with the SEC a registration statement on Form F-4 (the “Registration Statement”), which will consist of a proxy statement/prospectus and certain other related documents, which will serve as both a proxy statement/prospectus to be distributed to its shareholders in connection with the Business Combination and the solicitation of proxies for a vote by its shareholders with respect to the other matters described in the registration statement, as well as Even the prospectus. Relating to the offering and sale of securities to be issued to Pascal’s shareholders in connection with the completion of the business combination. This communication is not a substitute for the registration statement, definitive proxy statement/prospectus or any other document that Bleichroeder will send to its shareholders in connection with the Business Combination.
Before making any investment or voting decision, investors and security holders are advised to read, when available, the registration statement, proxy statement/prospectus and any other relevant documents and, in each case, any amendments filed with the SEC. Carefully and thoroughly, if and when they become available, as they will contain important information about the business combination, the related transactions and the parties to the business combination. Investors and security holders will be able to obtain copies of these documents (if and when available) and other documents filed with the SEC free of charge. www.sec.gov.
participants in solicitation
Under SEC rules, Bleichroeder, Pascal and certain of their respective directors, executive officers and other members of management, employees and consultants may be considered participants in the solicitation of proxies from Bleichroeder’s shareholders in connection with the business combination. A list of the names of Bleichroeder’s directors and executive officers and a description of their interests in Bleichroeder and the business combination is included in the sections titled “Management,” “Major Shareholders,” and “Certain Relationships and Related Party Transactions” of Bleichroeder’s final prospectus filed with the SEC on January 8, 2026 and the Current Report on Form 8-K filed with the SEC on January 9. 2026, each of which is available for free on the SEC’s website www.sec.gov. Information regarding persons who, under SEC rules, may be considered participants in the solicitation of proxies from Bleichroeder’s shareholders in connection with the business combination, and their direct and indirect interests, will be included in the registration statement and proxy statement/prospectus when they become available.
no offer or request
This communication is for informational purposes only and is not (i) an offer to buy, nor a solicitation of an offer to sell, subscribe for or purchase any securities, nor shall there be any sale, issue or transfer of securities in any jurisdiction in contravention of applicable law nor (ii) a solicitation of any vote in any jurisdiction pursuant to a business combination or otherwise. No offering of securities shall be made except by a prospectus meeting the requirements of Section 10 of the Securities Act of 1933 or an exemption therefrom. No securities commission or securities regulatory authority has in any way weighed in on the merits of the business combination or the accuracy or adequacy of this communication.
